Is Medical Pot a Blessing for Seniors?
In states that legalized medical marijuana, there was a 4.8 percent decrease in reported pain for conditions that qualified for pot treatment (cancer, arthritis, glaucoma and pain), compared to states without medical marijuana. (Source: WebMD Health)
Source: WebMD Health - March 20, 2019 Category: Consumer Health News Source Type: news

From reduced glaucoma risk to better skin, here are 8 reasons to eat collard greens
(Natural News) If you’re planning to add more greens in your diet, try collard greens, also known as collards. These loose-leafed vegetables are commonly grown in the southern parts of the world, including Portugal, Brazil, and the southern U.S. These greens are a great addition to your diet because they offer these health benefits: Collard... (Source: NaturalNews.com)
Source: NaturalNews.com - March 20, 2019 Category: Consumer Health News Source Type: news

Ivantis touts 2-year Hydrus, Glaukos iStent head-to-head study results
Ivantis today released two-year results from a study comparing its Hydrus Microstent to Glaukos‘ (NYSE:GKOS) iStent trabecular micro-bypass stents, touting reductions in medication use and no reoperations for patients in the Hydrus arm. The Irvine, Calif.-based company said that it is presenting results from the Compare trial today at the American Glaucoma Society’s annual meeting in San Francisco. “We are extremely pleased with these two year results. These results illustrate the clinical advantages of the Hydrus and its unique, proprietary Tri-Modal mechanism of action relative to focal trabecular ...
Source: Mass Device - March 14, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Glaukos Ivantis Source Type: news

Clinical Study Demonstrates Long Term IOP Reduction with the OMNI(R) Surgical System Predicate Device (TRAB(R)360) in Micro-Invasive Glaucoma Surgery
MENLO PARK, Calif., March 14, 2019 -- (Healthcare Sales & Marketing Network) -- A new, single center retrospective study of glaucoma surgery patients published in the January 2019 issue of Clinical Ophthalmology shows that ab-interno trabeculotomy using o... Devices, Ophthalmology Sight Sciences, OMNI Surgical System, TRAB360, trabeculotomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2019 Category: Pharmaceuticals Source Type: news

Aerie wins FDA nod for second glaucoma drug
Aerie Pharmaceuticals (NSDQ:AERI) said this week that the FDA approved the company’s once-daily eye drop Rocklatan for the treatment of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension. The Durham, N.C.-based company’s product is a fixed-dose combination of latanoprost and netarsudil – the active ingredient in Aerie’s first drug, Rhopressa. Get the full story at our sister site, Drug Delivery Business News. The post Aerie wins FDA nod for second glaucoma drug appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured Food & Drug Administration (FDA) Optical/Ophthalmic Pharmaceuticals Regulatory/Compliance Wall Street Beat Aerie Pharmaceuticals Source Type: news

Glaucoma eye warning: Glaucoma can lead to blindness - three symptoms to watch out for
GLAUCOMA is one of the biggest causes of blindness in the world, but how do you know if you have it or if you are at risk? This World Glaucoma Week, Specsavers reveals the three main symptoms of the eye condition and who might be at risk of developing it. (Source: Daily Express - Health)
Source: Daily Express - Health - March 14, 2019 Category: Consumer Health News Source Type: news

FDA OKs Rocklatan, a New Once-Daily Eye Drop for Glaucoma FDA OKs Rocklatan, a New Once-Daily Eye Drop for Glaucoma
The netarsudil and latanoprost ophthalmic solution (Rocklatan) reduces elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 14, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

Aerie Pharmaceuticals receives second FDA approval for glaucoma drug
(Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 13, 2019 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension
DURHAM, N.C.--(BUSINESS WIRE)--Mar. 12, 2019-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 12, 2019 Category: Drugs & Pharmacology Source Type: news

How Common Is Unintentional Cannabis Ingestion?
Discussion “[Cannabis] is a genus of flowering plant with three main varieties: sativa, indica and ruderalis.” It has been used for hundreds of years for hemp or fiber and also for psychoactive and medicinal effects. The active compounds are collectively called cannabinoids, of which delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant. The floral buds or calyxes of the plant have the most cannabinoids, but other parts of the plant are also used such as leaves. Hash oil, hashish (or resin) and marijuana (dried leaves) are the common products from strongest to least strongest products. ...
Source: PediatricEducation.org - March 11, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

15-minute laser treatment best for glaucoma
Trial results suggest new treatment could save the NHS £250m a year Related items fromOnMedica Two out of three hospital eye units reliant on locums to fill senior doctor posts Tackle continuing eye care crisis now, royal college urges Hunt Number of FGM concerns in children has more than doubled over past year Harms out-weight benefits for knee surgery for persistent pain Huge surge in rejection of requests for knee and hip surgery (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 11, 2019 Category: UK Health Source Type: news

15-minute laser is best treatment for glaucoma patients, says study
Top surgeon hails fast procedure that saves a lifetime using eye dropsLasers should become the principal method in the UK for treating patients with the debilitating eye condition glaucoma. That is the stark conclusion of a three-year study published on Sunday.The report, which appears in theLancet, says the laser technique – known as selective laser trabeculoplasty or SLT – should replace the prescribing of eye drops, the current favoured way to treat glaucoma. The study has revealed that SLT is not only more effective and safer, but should also save the NHS £1.5m a year in tackling the condition.Continu...
Source: Guardian Unlimited Science - March 9, 2019 Category: Science Authors: Robin McKie science editor Tags: Health NHS Society Science Source Type: news

Exfoliation Syndrome May Up Risk for COPD
FRIDAY, March 8, 2019 -- Patients with exfoliation syndrome (XFS) may be at increased risk for chronic obstructive pulmonary disease (COPD), according to a study published in the January-February issue of Ophthalmology Glaucoma. Samuel C. Taylor,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2019 Category: Pharmaceuticals Source Type: news

HEALTH NOTES: Vision boosted by video glasses  
HEALTH NOTES: The £6,000 Oxsight Prism glasses (pictured) are designed for those with reduced peripheral vision caused by diabetes and glaucoma. (Source: the Mail online | Health)
Source: the Mail online | Health - March 4, 2019 Category: Consumer Health News Source Type: news

New Treatment Modalities and Adherence in Glaucoma New Treatment Modalities and Adherence in Glaucoma
Might offering new treatment options help improve adherence among glaucoma patients?Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 28, 2019 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news

Glaucoma Burden Increasing Globally but Not Equally
TUESDAY, Feb. 26, 2019 -- The health burden of glaucoma increased globally in the past 25 years and is distributed unequally, according to a study published online Feb. 20 in Acta Ophthalmologica. Wei Wang, from Sun Yat-Sen University in Guangzhou,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2019 Category: Pharmaceuticals Source Type: news

Two-Stent Injection Lowers IOP in Various Glaucoma Types Two-Stent Injection Lowers IOP in Various Glaucoma Types
Dr Shuchi Patel on the latest results with the trabecular microbypass iStent inject.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 25, 2019 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Low-Tension Glaucoma: An Oxymoron in Ophthalmology Low-Tension Glaucoma: An Oxymoron in Ophthalmology
This paper explores the controversies surrounding the diagnostic entity low-tension glaucoma. Is it a contradiction in terms--and should symptoms be attributed to other causes?Preventing Chronic Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Glaucoma WARNING: Having this colour eyes could mean you’re at risk of losing your vision
GLAUCOMA symptoms don ’t usually appear in the early stages and tend to develop over a number of years. But a certain eye colour could mean you’re at increased risk of the condition, which can lead to vision loss. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2019 Category: Consumer Health News Source Type: news

Glaucoma WARNING: This eye colour could mean you’re at risk of losing your vision
GLAUCOMA symptoms don ’t usually appear in the early stages and tend to develop over a number of years. But a certain eye colour could mean you’re at increased risk of the condition, which can lead to vision loss. (Source: Daily Express - Health)
Source: Daily Express - Health - February 12, 2019 Category: Consumer Health News Source Type: news

Glaucoma WARNING: Watch out for this sign in your eye - you could have the condition
GLAUCOMA is an eye condition where the optic nerve connecting the eye to the brain becomes damaged. Left undiagnosed or not treated early enough, it can lead to loss of sight. While the damage happens inside eye, one symptom maybe be visible from the outside. (Source: Daily Express - Health)
Source: Daily Express - Health - February 6, 2019 Category: Consumer Health News Source Type: news

Two out of three hospital eye units reliant on locums to fill senior doctor posts
Latest workforce census points to severe shortages amid rapidly rising demand Related items fromOnMedica Primary open angle glaucoma Acute angle closure glaucoma Tackle continuing eye care crisis now, royal college urges Hunt Stem cell 'patch' offers hope for macular degeneration (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 1, 2019 Category: UK Health Source Type: news

New treatment target emerging for retinal damage
(Medical College of Georgia at Augusta University) Scientists at the Medical College of Georgia at Augusta University are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2019 Category: International Medicine & Public Health Source Type: news

What Are Common Causes of Blindness in Children?
Discussion According to the World Health Organization, about 1.3 billion people have some form of visual impairment. Most people with visual impairments are>50 years old, more are female than male, and more live in resource-limited areas than resource-rich areas. Most visual impairments are avoidable (80%) in all age groups with the leading causes globally and across ages being uncorrected refractive errors and cataracts. The most common causes of blindness are: Refractive errors, uncorrected Cataract Age-related macular degeneration Glaucoma Diabetic retinopathy Corneal opacity Trachoma The exact numbers vary by regi...
Source: PediatricEducation.org - January 28, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Renewal of driving license in India and glaucoma: a study of prevalent practice and its lacunae - Murthy GJ, Deshmukh AV, Mallidi AR, Murthy PR, Kattige JS, Murthy VR.
PURPOSE: Glaucoma affects different aspects of vision including visual field. This prospective observational study aims to collect details of driving license (DL) renewal procedure (in an urban metro in India) among patients with diagnosed glaucoma and the... (Source: SafetyLit)
Source: SafetyLit - January 25, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Low-Tension Glaucoma: An Oxymoron in Ophthalmology
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - January 24, 2019 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Predictors of falls per step and falls per year at and away from home in glaucoma - Ramulu PY, Mihailovic A, West SK, Gitlin LN, Friedman DS.
OBJECTIVE: To determine where glaucoma patients most often fall and how integrated visual field (IVF) damage affects falls rates per year (falls/year) and per step (falls/step) at and away from home. DESIGN: Prospective, observational cohort study ... (Source: SafetyLit)
Source: SafetyLit - January 17, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

SightGlass Vision launches trial for pediatric myopia-controlling eyeglasses
Opthalmalogical device maker SightGlass Vision said yesterday that it launched a pivotal clinical trial exploring the use of its novel lenses designed to reduce the rate of progression in children between six and nine years old. The Palo Alto, Calif.-based company’s Cypress trial is a multicenter, double-blinded, randomized controlled clinical trial that aims to enroll 255 patients across 14 clinical sites in the U.S. and Canada. The primary endpoint of the trial is the progression of myopia over 36 months, the company said. SightGlass Visions’s lenses are intended to reduce the progression of myopia, something...
Source: Mass Device - January 11, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic sightglassvision Source Type: news

Take Diabetes Into Consideration When Assessing for Glaucoma Take Diabetes Into Consideration When Assessing for Glaucoma
Diabetes and hyperglycemia are associated with thicker central corneal thickness, a relationship that could lead to overestimation of intraocular pressure, researchers warn ophthalmologists.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Glaukos Keeps Its Eye on the Prize at J.P. Morgan
Glaukos is probably at the top of its game when it comes down to maintaining a presence in the micro-invasive glaucoma surgery (MIGS) market. The San Clemente, CA-based company reaffirmed its laser-like focus on the market during a presentation at the 37th annual J.P. Morgan Healthcare Conference earlier on Wednesday. Glaukos’ CEO Thomas Burns began his presentation speaking on the strengths of the firm and its goals going forward. “Our mission is aspirational,” Burns said. “As a company we are seeking to transform glaucoma therapy, and in doing so we ...
Source: MDDI - January 10, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Globus Medical gains on Street-beating prelims | Wall Street Beat
Globus Medical (NYSE:GMED) shares closed up yesterday after the orthopedics company reported preliminary fourth-quarter and 2018 sales numbers that beat the consensus forecast on Wall Street. Audubon, Pa.-based Globus said it expects to post Q4 revenues of $195.5 million and full-year sales of $712.5 million; analysts on The Street were looking for quarterly sales of $188.2 million and annual sales of $705.2 million. “Our fourth-quarter and full-year results are indicative of strong momentum in several key strategic areas,” CEO Dave Demski said in prepared remarks. “The fourth quarter marke...
Source: Mass Device - January 9, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured MassDevice Earnings Roundup Wall Street Beat conformis Globus Medical Iridex Corp. Neuronetics Tactile Systems Technology Source Type: news

Netarsudil Lowers IOP, but When Should It Be Given? Netarsudil Lowers IOP, but When Should It Be Given?
Findings from the ROCKET trials shed light on --and also raise questions about --this newly approved medication for glaucoma.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2019 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

LIGHTMED Corporation Founder and Executive Chairman Gary Lee Reassumes CEO Role
SAN CLEMENTE, Calif., Jan. 2, 2019 -- (Healthcare Sales & Marketing Network) -- LIGHTMED Corporation, a global medical technology company, announced the reappointment of Founder and Executive Chairman Gary Lee as Chief Executive Officer, effective immedia... Devices, Ophthalmology, Dermatology, Personnel LIGHTMED, laser, cataract, glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 2, 2019 Category: Pharmaceuticals Source Type: news

Nicox teams up with Chinese firm to develop and sell glaucoma drug
French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China. (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Study suggests CBD may worsen glaucoma, raise eye pressure
(Indiana University) A study from researchers at Indiana University has found that CBD -- a major chemical component in marijuana -- appears to increase pressure inside the eye of mice, suggesting the use of the substance in the treatment of glaucoma may actually worsen the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 17, 2018 Category: International Medicine & Public Health Source Type: news

EHR-Linked Reminder System for Glaucoma Meds Perceived Useful
FRIDAY, Dec. 14, 2018 -- Patients with glaucoma generally find an electronic health record (EHR)-linked reminder system for glaucoma medications useful, according to a study published online Dec. 13 in JAMA Ophthalmology. Varshini Varadaraj,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2018 Category: Pharmaceuticals Source Type: news

Study points to potential new target in glaucoma research
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - December 13, 2018 Category: Hospital Management Tags: Hospital News Source Type: news

Reduce your risk of macular degeneration by a whopping 61% just by eating oranges
(Natural News) In the U.S., more people lose their vision because of age-related macular degeneration than glaucoma and cataracts combined, says the National Institute of Health (NIH). This makes the condition the leading cause of blindness among people older than 60. Macular degeneration is irreversible, but there are steps you can take to lower your... (Source: NaturalNews.com)
Source: NaturalNews.com - December 4, 2018 Category: Consumer Health News Source Type: news

‘Breakthrough’ eye-pressure sensor trial begins in Germany
(Image courtesy of Implandata) Implandata Ophthalmic Products announced that the first patient in its international, multi-center, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the suprachoroidally placed Eyemate-SC, a sensor implant for continual monitoring of intraocular pressure (IOP). While Implandata’s already CE-marked Eyemate-IO intraocular sensor implant is intended for use in glaucoma patients undergoing cataract surgery, the Eyemate-SC device allows implantation in glaucoma patients not indicated fo...
Source: Mass Device - December 3, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Optical/Ophthalmic Research & Development Implandata Ophthalmic Products Source Type: news

How Can Nanotechnologies Aid Implantable Drug-Delivery Systems?
Implantable technologies have come a long way over the years, and advancements in micro and nanotechnologies have helped device developers continue to push the envelope even further. Within the realm of drug delivery, advances in nanotechnologies have consistently improved patient outcomes by enabling sustained drug delivery to help treat chronic conditions. These scalable technologies have even offered localized drug delivery that can further improve bioavailability. While many of these technologies offer a variety of opportunities, we’re still eagerly awaiting to see the impact of these advancements onc...
Source: MDDI - November 29, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: BIOMEDevice San Jose Implants Source Type: news

Glaucoma referral scheme showing results
Recent research by the College of Optometrists shows that a glaucoma scheme in Manchester has successfully filtered patients with low false positive and false negative rates. The results should interest commissioners considering glaucoma pathways. (Source: NHS Networks)
Source: NHS Networks - November 22, 2018 Category: UK Health Source Type: news

A major step toward non-viral ocular gene therapy using laser and nanotechnology
(Polytechnique Montr é al) Gold nanoparticles, which act like 'nanolenses,' concentrate the energy produced by the extremely short pulse of a femtosecond laser to create a nanoscale incision on the surface of the eye's retina cells. This technology, which preserves cell integrity, can be used to effectively inject drugs or genes into specific areas of the eye, offering new hope to people with glaucoma, retinitis or macular degeneration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2018 Category: International Medicine & Public Health Source Type: news

Performance-based visual field testing for drivers with glaucoma: a pilot study - Devos H, Ranchet M, Bollinger K, Conn A, Akinwuntan AE.
OBJECTIVE: Conventional visual field (VF) tests are limited in predicting on-road driving performance of individuals with glaucoma. We developed a new performance-based VF test in a driving simulator for individuals with glaucoma. The aim was to evaluate t... (Source: SafetyLit)
Source: SafetyLit - November 17, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Small-Particle Air Pollution May Raise Glaucoma Risk in Some Small-Particle Air Pollution May Raise Glaucoma Risk in Some
In people who already have a genetic vulnerability, small-particle air pollution known as black carbon may raise the risk of developing glaucoma, a new study suggests.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - November 16, 2018 Category: Opthalmology Tags: Ophthalmology News Source Type: news

Small-particle air pollution may raise glaucoma risk in some
(Reuters Health) - In people who already have a genetic vulnerability, small-particle air pollution known as black carbon may raise the risk of developing glaucoma, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Purdue's giant leap toward personalized medicine helps eyes drain themselves
(Purdue University) Purdue University researchers created a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyesight. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2018 Category: International Medicine & Public Health Source Type: news

Normal-Tension Glaucoma
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 6, 2018 Category: General Medicine Source Type: news

Meditation: An effective new therapy to reduce eye pressure in primary open-angle glaucoma
(Institute for Medical Psychology, Otto-v.-Guericke University Magdeburg) A new era in the management of glaucoma is ushered in by a landmark study published in the Journal of Glaucoma, Official Journal of the World Glaucoma Association. Patients with primary open angle glaucoma (POAG) showed significant improvements of both ocular and general health after participating in a program of mindful meditation focused on breathing compared to the control group that did not partake. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 5, 2018 Category: International Medicine & Public Health Source Type: news

Nearly 200 UCLA volunteers treat the uninsured at the annual Care Harbor free clinic
When Andre Buchanan was 12, he fell from a tree and destroyed a front tooth. Although a dentist fixed the tooth at the time, it deteriorated over the many years since and  two years ago the now adult Buchanan had only a nub for a tooth.Each year at family events, his mother would nag him about the tooth. “Boy,” she’d tell him, “you ain’t fixed that tooth yet?’”Then Andre heard about the annual Care Harbor clinic in downtown Los Angeles that provides free health, dental and eye care to people who don ’t have access to it. He emerged with a perfect new tooth that he p...
Source: UCLA Newsroom: Health Sciences - November 1, 2018 Category: Universities & Medical Training Source Type: news

What is a falls risk factor? Factors associated with falls per time or per step in individuals with glaucoma - Ramulu PY, Mihailovic A, West SK, Friedman DS, Gitlin LN.
OBJECTIVES: To determine whether visual field (VF) damage or other factors confer a similar risk of falling when falls are ascertained as a rate over time (falls/year) as when ascertained over activity (falls/step). DESIGN: Prospective, observation... (Source: SafetyLit)
Source: SafetyLit - October 30, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news